Stenotrophomonas maltophilia infections

被引:29
|
作者
Dignani, MC
Grazziutti, M
Anaissie, E
机构
[1] Univ Arkansas Med Sci, Arkansas Canc Res Ctr, Myeloma Inst Res & Treatment, Little Rock, AR 72205 USA
[2] FUNDALEU, Buenos Aires, DF, Argentina
[3] FUNCEI, Buenos Aires, DF, Argentina
关键词
Stenotrophomonas maltophilia; nosoconnial infections; immunocompromised host;
D O I
10.1055/s-2003-37920
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Stenotrophomonas maltophilia is a ubiquitous, gram-negative organism that causes hospital-acquired infections. Persons often come in contact with S. maltophilia through environmental water sources, including hospital tap water or faucets, and it has been associated with nosocomial outbreaks of infection. S. maltophilia often infects debilitated persons and those with underlying medical conditions, including immunosuppression. Manifestations of infection include pneumonia, often in mechanically ventilated patients, bacteremia, skin and soft tissue infection, urinary tract infection, and endocarditis. Treatment of S. mallophilia infection is difficult because the organism is resistant to a number of agents typically used for hospital-acquired infections. In vitro and clinical data indicate that trimethoprim-sulfamethoxazole is the agent of choice. Beta-lactamase inhibitors such as clavulanate are also active, and combination therapy may be indicated for certain serious infections due to S. maltophilia.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 50 条
  • [1] Stenotrophomonas maltophilia ocular infections
    Penland, RL
    Wilhelmus, KR
    ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (04) : 433 - 436
  • [2] Antimicrobial therapy for Stenotrophomonas maltophilia infections
    A. C. Nicodemo
    J. I. Garcia Paez
    European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 229 - 237
  • [3] Antimicrobial therapy for Stenotrophomonas maltophilia infections
    Nicodemo, A. C.
    Garcia Paez, J. I.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (04) : 229 - 237
  • [4] Stenotrophomonas maltophilia - Clinical Significance, Treatment of Infections
    Nowicka, Joanna
    Janczura, Adriana
    Lelonkiewicz, Martyna
    ADVANCEMENTS OF MICROBIOLOGY, 2023, 62 (3-4) : 133 - 143
  • [5] Treatment approaches for severe Stenotrophomonas maltophilia infections
    Mojica, Maria F.
    Bonomo, Robert A.
    van Duin, David
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (06) : 572 - 584
  • [6] The epidemiology of Stenotrophomonas maltophilia and Achromobacter xylosoxidans infections
    Zilberman-Itskovich, Shani
    Cohen, Edward
    Ploshansky, Leonid-Arie
    Yusupov, Alexander
    Bouganim, Ruth
    Jaffe, Katie H.
    Marchaim, Dror
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2024, 4 (01):
  • [7] Infections Caused by Stenotrophomonas maltophilia– A Prospective Study
    R. Schaumann
    K. Stein
    C. Eckhardt
    G. Ackermann
    A.C. Rodloff
    Infection, 2001, 29 : 205 - 208
  • [8] Infections caused by Stenotrophomonas maltophilia -: A prospective study
    Schaumann, R
    Stein, K
    Eckhardt, C
    Ackermann, G
    Rodloff, AC
    INFECTION, 2001, 29 (04) : 205 - 208
  • [9] Stenotrophomonas maltophilia in Lower Respiratory Tract Infections
    Chawla, Kiran
    Vishwanath, Shashidhar
    Gupta, Ashu
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (12) : DC20 - DC22
  • [10] Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections
    Tekce, Yasemin Tezer
    Erbay, Ayse
    Cabadak, Hatice
    Sen, Suha
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (03) : 150 - 154